Abstract:Purpose: Chronic myelogenous leukemia (CML) is a disease characterized cytogenetically by the presence of the Philadelphia chromosome. Recent studies suggested that altered PDCD5 expression may have significant implications in CML progression. The aim of this study was to identify single- nucleotide polymorphisms (SNP) within the programmed cell death 5 (PDCD5) promoter region and show their functional relevance to PDCD5 expression as well as their genetic susceptibility to CML.Experimental Design: One hundred twenty-nine CML subjects and 211 healthy controls were recruited for identification of SNPs and subsequent genetic analysis. Luciferase reporter assays were carried out to show the functional significance of the SNPs located in the promoter region to PDCD5 expression. Real-time quantitative PCR and Western blot analysis were done to determine the expression differences of PDCD5 in CIVIL patients with different genotypes.Results: Two SNPs were identified within the PDCD5 promoter. They are -27A > G and -11G > A (transcription start site as position, 1), respectively. The complete linkage disequilibrium was found between these two polymorphisms. The frequencies of -27G(+)/-11A(+) genotype and -27G/-11A allele were significantly higher in CML patients than in healthy controls (genotype: 26.36% versus 11.85%, chi(2)=11.75, P < 0.01; allele: 13.57% versus 6.40%, chi(2) = 9.48, P < 0.01). Luciferase reporter assays revealed that the promoter with -27G/-11A had significantly lower transcriptional activity and could not be up-regulated after apoptotic stimulations compared with the promoter with -27A/-11G. PDCD5 expression analysis in mononuclear cells derived from CML patients and cell lines with different -27/-11 genotypes showed consistent results with the reporter assays.Conclusions: These data suggest that -27G/-11A is associated with reduced PDCD5 promoter activity and increased susceptibility to CML.

[In Silico Data Mining of the Human Programmed Cell Death 5 (PDCD5) Sequences].

PDCD5 (programmed Cell Death 5)

Structure-Function Correlation of Human Programmed Cell Death 5 Protein

Cyclin Dependent Kinase 5 and Its Interacting Proteins in Cell Death Induced in Vivo by Cyclophosphamide in Developing Mouse Embryos

Cellular functions of programmed cell death 5.

Cellular Uptake of Exogenous Human PDCD5 Protein

Cloning and Sequencing of a Drosophila cDNA Homologous to Programmed Cell Death 5 (PDCD5) Gene

Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis

The 5'-upstream region of human programmed cell death 5 gene contains a highly active TATA-less promoter that is up-regulated by etoposide.

Solution Structure of S. Cerevisiae PDCD5-like Protein and Its Promoting Role in H(2)O(2)-induced Apoptosis in Yeast.

Pan-cancer Analysis of Oncogenic Role of Programmed Cell Death 2 Like (PDCD2L) and Validation in Colorectal Cancer

NMR Studies of the Interaction Between Human Programmed Cell Death 5 and Human P53.

Programmed Cell Death 4 is an Inhibitor of Autophagy Via Targeting ATG5 (P1371)

Role of Programmed Cell Death 4 in Diseases: a Double-Edged Sword

Pdcd5-Regulated Cell Fate Decision after Ultraviolet-Irradiation-Induced Dna Damage

PDCD5 functions as a regulator of p53 dynamics in the DNA damage response

The Role of Charged Multivesicular Body Protein 5 in Programmed Cell Death in Leukemic Cells

PDCD5 interacts with p53 and functions as a regulator of p53 dynamics in the DNA damage response

Two Single-Nucleotide Polymorphisms With Linkage Disequilibrium In The Human Programmed Cell Death 5 Gene 5 ' Regulatory Region Affect Promoter Activity And The Susceptibility Of Chronic Myelogenous Leukemia In Chinese Population

The N-terminal 26-Residue Fragment of Human Programmed Cell Death 5 Protein Can Form a Stable Alpha-Helix Having Unique Electrostatic Potential Character.

Function and application prospects of the new apoptosis-related gene PDCD5 in apoptosisGUO Hui,SUN Wei,MA Xiu-min,